Akari Therapeutics to showcase novel PH1 ADC payload platform
Akari Therapeutics says it was invited to present its next-generation ADC payload innovation at five U.S. and China conferences in September, with CEO Abizer Gaslightwala delivering keynote and featured talks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.